scispace - formally typeset
L

Li Yang

Researcher at Sichuan University

Publications -  371
Citations -  6789

Li Yang is an academic researcher from Sichuan University. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 35, co-authored 295 publications receiving 4474 citations.

Papers
More filters
Journal ArticleDOI

Immunotherapy of tumors with xenogeneic endothelial cells as a vaccine

TL;DR: It is shown that immunotherapy of tumors using fixed xenogeneic whole endothelial cells as a vaccine was effective in affording protection from tumor growth, inducing regression of established tumors and prolonging survival of tumor-bearing mice.
Journal ArticleDOI

Immunogene therapy of tumors with vaccine based on xenopus homologous vascular endothelial growth factor as a model antigen

TL;DR: It is found that immunogene tumor therapy with a vaccine based on XVEGF was effective at both protective and therapeutic antitumor immunity in several tumor models in mice, and may provide a vaccine strategy for cancer therapy through the induction of autoimmunity against the growth factors associated with tumor growth.
Journal ArticleDOI

Silencing of pkm2 increases the efficacy of docetaxel in human lung cancer xenografts in mice.

TL;DR: The effects of combining shRNA targeting PKM2 and docetaxel on human A549 lung carcinoma cells both in vivo and in vitro suggest that targeting tumor glycolysis can increase the efficacy of chemotherapy.
Journal ArticleDOI

Inflammation-Responsive Drug-Loaded Hydrogels with Sequential Hemostasis, Antibacterial, and Anti-Inflammatory Behavior for Chronically Infected Diabetic Wound Treatment.

TL;DR: In this paper, a dual-responsive (pH and reactive oxygen species (ROS)) hydrogel was prepared to realize drug release properties under inflammatory stimulation by grafting 3-carboxy-phenylboronic acid to the gelatin molecular backbone and cross-linking with poly(vinyl alcohol).
Journal ArticleDOI

Synergistic effects of antimicrobial peptide DP7 combined with antibiotics against multidrug-resistant bacteria.

TL;DR: AMP DP7 plus the antibiotic AZT or VAN is more effective, especially against highly antibiotic-resistant strains, particularly against highly resistant strains carrying more than two AZT-resistance genes.